Related Experiment Video
Updated: Mar 27, 2026

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
The Shp2-induced epithelial disorganization defect is reversed by HDAC6 inhibition independent of Cdc42
Sui-Chih Tien1, Hsiao-Hui Lee2, Ya-Chi Yang1
1Institute of Biochemistry and Molecular Biology, National Yang-Ming University, No. 155, Section 2, Linong Street,Taipei 11221, Taiwan.
Abstract:
Regulation of Shp2, a tyrosine phosphatase, critically influences the development of various diseases. Its role in epithelial lumenogenesis is not clear. Here we show that oncogenic Shp2 dephosphorylates Tuba to decrease Cdc42 activation, leading to the abnormal multi-lumen formation of epithelial cells. HDAC6 suppression reverses oncogenic Shp2-induced multiple apical domains and spindle mis-orientation during division in cysts to acquire normal lumenogenesis. Intriguingly, Cdc42 activity is not restored in this rescued process. We present evidence that simultaneous reduction in myosin II and ERK1/2 activity by HDAC6 inhibition is responsible for the reversion. In HER2-positive breast cancer cells, Shp2 also mediates Cdc42 repression, and HDAC6 inhibition or co-suppression of ERK/myosin II promotes normal epithelial lumen phenotype without increasing Cdc42 activity. Our data suggest a mechanism of epithelial disorganization by Shp2 deregulation, and reveal the cellular context where HDAC6 suppression is capable of establishing normal epithelial lumenogenesis independent of Cdc42.
Insights
Oncogenic Shp2 causes abnormal epithelial cell structure by decreasing Cdc42 activity. HDAC6 suppression reverses this, restoring normal lumen formation independently of Cdc42 activity.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Shp2 tyrosine phosphatase regulates cell development and disease.
- The role of Shp2 in epithelial lumenogenesis remains unclear.
- Deregulation of Shp2 is implicated in various pathologies.
Purpose of the Study:
- To investigate the role of Shp2 in epithelial lumenogenesis.
- To elucidate the mechanism by which Shp2 influences epithelial cell organization.
- To explore therapeutic strategies targeting Shp2-mediated epithelial abnormalities.
Main Methods:
- Investigated Shp2's effect on Tuba dephosphorylation and Cdc42 activation in epithelial cells.
- Utilized HDAC6 suppression to reverse Shp2-induced defects in cyst lumen formation.
- Analyzed the impact of HDAC6 inhibition on myosin II and ERK1/2 activity.
- Examined Shp2 and HDAC6 roles in HER2-positive breast cancer cells.
Main Results:
- Oncogenic Shp2 dephosphorylates Tuba, reducing Cdc42 activation and causing abnormal multi-lumen formation.
- HDAC6 suppression restored normal lumenogenesis and spindle orientation in epithelial cysts.
- HDAC6 inhibition reduced myosin II and ERK1/2 activity, independent of Cdc42 restoration.
- HDAC6 inhibition or ERK/myosin II co-suppression promoted normal epithelial phenotype in breast cancer cells.
Conclusions:
- Shp2 deregulation contributes to epithelial disorganization via Tuba/Cdc42 pathway.
- HDAC6 suppression can rescue epithelial lumenogenesis defects independently of Cdc42.
- HDAC6 inhibition offers a potential therapeutic strategy for Shp2-related epithelial disorders, including breast cancer.
More Related Videos
Related Concept Videos
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
Hedgehog Signaling Pathway
The JAK-STAT Signaling Pathway
Anaphase Promoting Complex
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Inhibition of Cdk Activity

